Kendle is the world leader in planning, designing, implementing and managing pregnancy registries. We conduct more pregnancy registries than any other CRO. Our longest-running registry started 18 years ago and is still going strong, with evidence being collected and collated from 16 different pharmaceutical companies. So, we’re the perfect people to ask about your drug’s potential effects on pregnant women and their babies. Kendle's associates have advised and continue to collaborate with some of the world’s most eminent medical organizations in developing pregnancy registry guidance, including the U.S. Food and Drug Administration, the Agency for Healthcare Research and Quality, the World Health Organization and the Centers for Disease Control and Prevention.
Kendle is currently running 11 different registries for individual customers in addition to three larger, multi-participant registries. We’re adept at designing methodologies for a host of therapeutic areas and already have registered the outcomes of more than 20,000 patients. Additionally, we can provide risk management programs, epidemiology studies, systematic reviews and meta-analyses, to help you paint a detailed picture of your product’s use in the real-world setting.
Click here to view a listing of all active pregnancy registries